EUVIMEDEUVIMED entdecken
Open Access · CC BY-SA 4.0

Neopterin and Interferon Gamma: Unveiling Their Prognostic Potential in COVID-19 with Diabetes Mellitus

Agustin Iskandar, Calica Aghata Laksmana, Catur Suci Sutrisnani

INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY · 10.11.2026 · 33 (1) · 100-105

DOI: 10.24293/ijcpml.v33i1.2665 ↗

Kurz gefasst

Fachartikel in der Zeitschrift INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY, online erschienen am 10.11.2026. Verfasst von Agustin Iskandar und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetes mellitus (DM) comorbidity increases the mortality risk in COVID-19 patients. Neopterin and Interferon-gamma (IFN-γ) are inflammatory markers involved in COVID-19 pathogenesis. This study aimed to evaluate the prognostic value of neopterin and IFN-γ as predictors of mortality in COVID-19 patients with DM comorbidity. We conducted a retrospective cohort study using clinical data and serum samples from COVID-19 patients with DM hospitalized at Dr. Saiful Anwar General Hospital, Malang, Indonesia, between January 2022 and July 2022. Neopterin and IFN-γ levels were measured from serum samples. This study included 179 COVID-19 patients: 94 with DM comorbidity and 85 without. The non-survival group had significantly higher neopterin levels than the survival group (p=0.0074). Path analysis showed that IFN-γ and neopterin each had independent prognostic effects on mortality, without functioning as confounders or intervening mediators along a single shared pathway. Kaplan-Meier curve analysis shows that IFN-γ levels ≥27.37 pg/mL and neopterin levels ≥9.770 nmol/L are associated with decreased life expectancy. In conclusion, neopterin and IFN-γ levels can serve as biomarkers for predicting mortality in COVID-19 patients with diabetes mellitus.

Zitieren

APA

Iskandar, A., Laksmana, C. A., & Sutrisnani, C. S. (2026). Neopterin and Interferon Gamma: Unveiling Their Prognostic Potential in COVID-19 with Diabetes Mellitus. INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY, 33(1), 100-105. https://doi.org/10.24293/ijcpml.v33i1.2665

Vancouver

Iskandar A, Laksmana CA, Sutrisnani CS. Neopterin and Interferon Gamma: Unveiling Their Prognostic Potential in COVID-19 with Diabetes Mellitus. INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY. 2026;33(1):100-105. doi:10.24293/ijcpml.v33i1.2665

BibTeX
@article{Iskandar2026,
  author = {Iskandar, Agustin and Laksmana, Calica Aghata and Sutrisnani, Catur Suci},
  title = {Neopterin and Interferon Gamma: Unveiling Their Prognostic Potential in COVID-19 with Diabetes Mellitus},
  journal = {INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY},
  year = {2026},
  volume = {33},
  number = {1},
  pages = {100--105},
  doi = {10.24293/ijcpml.v33i1.2665}
}
Kostenlos starten →